Outline
Outline
OUTLINE
You are invited to submit an abstract of an original research related to Respiratory Tract Infections for consideration the Forum Topics to be candidate as:
Rising Star
Topics
Topics
Topics Covered
Antibiotic Resistance
Bacterial Infection
Bronchiectasis
Covid-19
Exacerbation
Influenza
Lung Microbiome
Molecular Diagnostics
Novel Approaches
NTM – Non-Tuberculosis Mycobacterial
Pleural Infection
Pneumonia
RSV – Respiratory Syncytial Virus
Tuberculosis
Vaccines
Viral Infection
Two young researchers / clinicians, selected by a strict process, will have the opportunity to:
- Present their work in the main auditorium with Q&A from internationals experts.
Further details on timing and schedule of the lectures will be shared in due time.
- Receive the personal feedback of the Scientific Committee of
- the Forum who will provide useful advice for the development of the winners’ career as researchers and international conference faculty
- Receive a full hosting package (free registration, travel, and accommodation)
Concept
Concept
The Concept
Guidelines
Guidelines
Guidelines
Online submission
To participate in the selection process, please submit before 18 November 2024.
- Select the category “Rising Stars”
- Select the topic among the list, follow the instructions and complete your submission according to the rules.
- State the conflict-of-interest disclosures for each author at the end of the submitted abstract (If there are no conflict of interest, it should be stated as well).
- Upload a Full academic curriculum including publications and / or poster presentations made in the past
Compulsory criteria:
- Abstracts should be related to the topics of the Forum.
- The candidate should be the first author of the abstract.
- The abstract should be original.
- The abstract should be presented in English.
- The candidate should not have been included in the faculty of a previous international Forum.
The main selecting criteria will be the relevancy and scientific value of the abstract presented, evaluated by the Scientific Committee of the Forum. The choice will be made at the Scientific Committee’s discretion. In case of equality the following priority criteria will be applied.
Priority criteria:
- Age: Priority to researchers / clinicians under 42;
- Provenience: priority for researchers / clinicians working in low–income countries – with limited access to funds.
Acceptance
Notifications to submitters will be sent by the end of November 2024.
Please kindly note that if your rising star application is not accepted, it can be automatically considered for an oral or poster presentation.
Criteria
Criteria
Compulsory Criteria
Abstract submission is closed
Stars
RTI 2024
RTI 2024 Rising Stars
Rebecca Hull
Rebecca Hull is a postdoctoral research assistant in the respiratory research group at the University of Dundee. She completed her PhD at the University of Sheffield, before moving to Dundee to carryout work aiming to identify factors which predict bronchiectasis patient response to Pseudomonas targeting antibiotics and response to novel therapies.
100 Pseudomonas aeruginosa (PA) clones were isolated from sputum from 100 bronchiectasis patients. These clones had heterogenous genotypes, with some variants linked to changes in bacterial growth and biofilm formation. 17% of patients cleared these infections within 12-months. Low PA culture densities were associated with infection clearance. Genetic variants did not predict PA eradiation, nor did bacterial growth or biofilm formation parameters.
Clark Russell
Clark Russell is a clinical Lecturer in Infectious Diseases at the University of Edinburgh Centre for Inflammation Research. His main research interest is macrophage host defence against aerobic gram-positive cocci (streptococci, staphylococci, enterococci).
Investigation of pathogen adaptive variants provides a novel approach to identify mechanisms of host defence. We applied this approach to macrophage intracellular killing of pneumococci, identifying several anti-bacterial host factors in vitro. Therapeutic modulation of one pathway in vivo increased bacterial clearance in a mouse model of invasive pneumococcal disease.
